Article
Impact of ALDH1A1 and NQO1 gene polymorphisms on the response and toxicity of chemotherapy in Bangladeshi breast cancer patients.
Cancer chemotherapy and pharmacology - 1 Oct 2024
Islam Md Siddiqul, Akter Ferdowsi, Rahman Md Mosiqur, Rafe Md Rajdoula, Aziz Md Abdul, Parvin Salma, Mosaddek Abu Syed Md, Islam Mohammad Safiqul, Akter Md Wahid
Abstract excerpt
PURPOSE: Cyclophosphamide, Epirubicin/Doxorubicin, 5-fluorouracil (CEF or CAF) chemotherapy has long been a standard first-line treatment for breast cancer. The genetic variations of enzymes that are responsible for the metabolism of these drugs have been linked to altered treatment response and toxicity. Two drug-metabolizing enzymes ALDH1A1 and NQO1 are critically involved in the pathways of CEF/CAF metabolism....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
